The US health care system relies heavily on private markets. While private insurers, provider
organizations, and drug and device companies are familiar to many, little is known about the
increasing presence of venture capital in today's delivery system. The growth of venture
capital and venture capital-backed, early-stage companies (startups) deserves the attention
of patients and policy makers because advancements in medicine are no longer exclusively
born from providers within the delivery system and increasingly from innovators outside of …